# Cognitive Enhancement **Domain:** Neuroscience / Biopharmacology **Doc Type:** Concept Node **Classification:** Infrastructure Concept **Maturity:** Evolving **Related:** [[Neural Technology]], [[Performance Optimization]], [[Inequality]], [[Bioethics]], [[Competitive Advantage]], [[Human Modification]] --- ## Definition **Cognitive Enhancement** refers to **the use of pharmacological, technological, or genetic interventions to improve cognitive performance—including memory, attention, processing speed, or executive function—beyond baseline individual or population capacity, typically with the goal of task performance improvement or competitive advantage**. Enhancement can be modest (caffeine) or speculative (neural implants). --- ## General Context Cognitive enhancement encompasses diverse approaches: stimulant medications (prescribed or misused), nootropics (supplements with cognitive claims), transcranial stimulation, and speculative neural technologies. Enhancement is widely practiced in competitive contexts (academia, professional sports, business). Safety and efficacy vary widely; long-term effects are often unknown. Enhancement creates inequality (access is unequal) and arms races (if competitors enhance, pressure emerges to match). Ethical questions include personal autonomy, fairness, and potential harms. --- ## Climate Meritocracy Context Climate adaptation may include cognitive enhancement to improve decision-making under climate stress. [[articles/Climate Systems as Human Resilience Platforms|Resilience Platforms]] could include pharmaceutical or technological cognitive optimization. --- ## Key Insight Cognitive enhancement operationalizes **human performance as technological optimization problem**—risking the reduction of thinking to measurable processing capacity. --- ## See Also [[Behavioral Prediction]], [[Behavioral State Configuration]], [[Complex Systems]], [[Computational Governance]], [[Human Enhancement]]